Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

New mouse models help study melanocytic cells for melanoma research.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Nevus comedonicus can sometimes grow terminal hair, challenging previous beliefs.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

Nilotinib can cause generalized keratosis pilaris.

Intralesional steroid injections can effectively treat calcinosis and ulcers in scleroderma.

A woman had a unique skin growth with hair follicle, oil glands, fat cells, spindle cells, and nerve fibers.

CT scans can find serious prostate cancer even when PSA levels are low.

A benign skin tumor was removed from a man's leg, and it didn't come back after 9 months.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

LncRNAs may help improve brain cancer treatment and diagnosis.

CXCR2 in skin cells promotes tumor growth.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

ALRN-6924 may prevent hair loss caused by chemotherapy.

New techniques have enhanced our understanding of how stem cells function and the role of mutations in aging tissues, which may influence future cancer therapies.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Treatment reduced cystic lesions but didn't change existing Nevus Comedonicus.

Removing a tumor may resolve associated skin and hair symptoms.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.

SCAD can indicate ANA-negative lupus, especially in women with unusual symptoms.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

The man died from lung cancer, not the rare nail tumor.